1[1]Warburten-Timms VJ, Charlett A, Valori RM, et al. The significance of cagA(+) Helicobacter pylori in reflux oesophagitis. Gut, 2001 ; 49 (3) : 341
2[2]Rokkas T, Ladas SD, Triantafyllou K, et al. The association between CagA status and development of esophagitis after the eradication of Helicobacter pylori. Am J Med,2001;110(9) : 703
3[3]Robert V, Michel P, Flaman JM, et al. High frequency in esophageal cancers of p53 alterations inactivating the regulation of genes involved in cell cycle and apoptosis. Carcinogenesis, 2000; 21 (4) :563
4[4]Bian YS, Osterheld MC, Bosman FT, et al. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus. Mod Pathol,2001;14(5) : 397
5[5]Schneider PM, Casson AG, Levim B, et al.Mutations of P53in Barrett's esophagus and Barrett's cancer : a prospective study of ninety-eight cases. J Thorac Ca rdiovasc Surg, 1996 ; 111 (2) : 323
6[6]Halm U, Tannapfel A, Breitung B, et al. Apoptosis and cell proliferation in the metaplasia-dysplasiacarcinoma-sequence of Barrett's esophagus.Hepatogastroenterology, 2000 ; 47 (34) : 962
7[7]Brabender J, Lord RV, Danennberg KD, et al.Increased c-myb mRNA expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.J Surg Res, 2001;99(2) : 301
8[8]Sarbia M, Arjumand J, Wolter M, et al. Frequent cmyc amplification in high-grade dysplasia and adenocarcinoma in Barrett esophagus. Am J Clin Pathol, 2001;115(6) : 835
9[9]Souza RF, Shewmake K, Beer DG, et al. Selective inhibition of cyclooxygenase-2 suppresses growth and nduces apoptosis in human esophageal adenocarcinoma cell. Cancer Res, 2000; 60 (20) :5767
10[10]Li M,Wang XY,Xu XC. Induction of apoptosis by cyclo-oxygenase-2 inhibitor NS398 through a cytochrome C-dependent pathway in esophageal cancer cells. Int J Cancer , 2001; 93 : 218
二级参考文献8
1Katada N, Hinder RA, Smyrk TC, et al. Apoptosis is inhibited early in the dysplasia-carcinoma sequence of barrett esophagus. Arch Surg, 1997,728.
2Swami S, Kumble S, Triadfilopoulous G. E-cadherin expression in gas troesophageal reflux disease, barrett's esophagus, and esophageal adenocarcinoma: an immunohistochemical and immunoblot study. Am J Gastmenterol, 1995,90:1908.
3Orlando RC. Esophageal epithelial defenses against acid injury. AM J Gastroenterol,1994,89(8):S48.
4Dent J, Bremner CG, Collen MJ, et al. Working party report to the World Congressores of Gastroenterology, Sydney, 1990, Barrett's esophagus. J Gastroenterol Hepatol,1991,6:1.
5Hynes RO. Vesatility, modulation, and signalling in cell adhesion. Cell,1992,69:11.
6Kadowaki T, Shiozaki H, Inoue M, et al. E-cadherin and α-catenin expression in human esophageal cancer. Cancer Res, 1994,54:291.
7Katayama M, Hirai S, Kakihagi K, et al. Soluble E-cadherin fragments increased in circulation of cancer patients Br J Cancer,1994,69: 580.
